by Mark Lelinski | Sep 12, 2023 | Uncategorized
These days, clients often asked, “What is the greatest determinant of success (or failure) when conducting a major business transformation?”. Is it the need for senior leader sponsorship? Is it the importance of middle manager involvement from end-to-end? Is it the...
by Mark Lelinski | Aug 10, 2023 | Uncategorized
In this special edition of the Frog Blog, we will take a closer look at the recent efforts of global life science companies to up their game in the area of environmental sustainability. In other words, can the biopharmaceutical industry continue to deliver innovative,...
by Mark Lelinski | Jul 10, 2023 | Uncategorized
In 2015, I founded a healthcare technology start-up that used AI and machine learning to help health systems select the exact right medication, for the right patient, at the right time in treatment, all at the right price. Our value, while ambitious and evidence...
by Mark Lelinski | Jun 16, 2023 | Uncategorized
Digital transformation of the customer experience in life sciences can be more challenging than more traditional organization changes, for several reasons. So, let’s jump right in and understand the main hurdles, and then perhaps, we can finally clear the way to the...
by Mark Lelinski | May 15, 2023 | Uncategorized
In the life sciences industry, the cornerstones of a company’s value chain are well known to be R&D (where medicines are discovered and developed) and Commercialization (where medicines are marketed, sold, and accessed). Central to the success of any prescription...
